What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially announce and provide access to Merck & Co., Inc.'s financial results for the fourth quarter and the full year of 2013. It acts as a formal notification to investors and the public about the company's earnings performance.

Where can I find the actual financial numbers and details of Merck's Q4 and Full Year 2013 results?

The 8-K itself does not contain the detailed financial figures. Instead, it incorporates by reference two exhibits: Exhibit 99.1 (a press release) and Exhibit 99.2 (supplemental information). Investors need to refer to these attached exhibits for the specific revenue, earnings, and other financial data.

Does this 8-K filing contain forward-looking guidance?

While this 8-K filing serves as the vehicle for announcing historical results, the incorporated press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) would typically contain forward-looking statements and guidance for future periods. Investors should examine these exhibits for any outlook provided by Merck management.

Is the information in this 8-K considered 'filed' or 'furnished'?

According to the filing itself, the information furnished pursuant to Item 2.02 (Results of Operations and Financial Condition) shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section. This means it's generally considered 'furnished' rather than 'filed' in that specific context, although the 8-K report itself is a required filing.

MRK 8-K: Earnings & Results

Summary

Merck & Co., Inc. (MRK) filed an 8-K report on February 5, 2014, to announce its financial results for the fourth quarter and full year of 2013. The filing incorporates by reference a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) detailing these earnings. Investors should review these attached documents for specific financial performance, key operational metrics, and guidance for the upcoming periods. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification and public disclosure mechanism for Merck's earnings announcement. The incorporated exhibits are critical for understanding the company's revenue generation, profitability, and any significant factors impacting its financial condition as of the reporting date. Investors are advised to consult these exhibits for a comprehensive understanding of Merck's performance and outlook.

Key Highlights

1Merck filed an 8-K on February 5, 2014, to report Q4 and Full Year 2013 earnings.
2The report incorporates by reference a press release detailing the financial results.
3Supplemental financial information not included in the press release is also incorporated.
4Investors can access specific Q4 and Full Year 2013 financial performance details through the referenced exhibits.
5The filing is an official notification of Merck's earnings announcement for the period.
6The incorporated exhibits are essential for a complete understanding of Merck's financial condition and results.

Merck & Co., Inc. 8-K Report, Financial Results (Feb 5, 2014)

Summary

Key Highlights

Frequently Asked Questions